Buy Stugeron
Stugeron

$0.69
Active Ingredient
Delivery
Airmail (14-21 days) | EMS trackable (5-9 days)
Prescription
Issued on site / Included
Availability
In Stock
Product is shipped in a fully discreet envelope with no content disclosure, including all required documentation inside

Stugeron Properties

Active Ingredients
Pharmacological Class
H1 Antagonist, Calcium Channel Blocker (mild)
Minor Side Effects
Moderate Side Effects
Dosage Forms
Tablets
Administration Route
Oral
Mechanism of Action
Reduces symptoms of dizziness and nausea by affecting blood flow to the inner ear and brain, and by blocking histamine receptors.
Prescription Status
OTC
Patient Summary
Used to prevent and treat symptoms of motion sickness, dizziness, and balance problems.
Onset Time
Within 30 minutes to 1 hour
Duration
4-6 hours
Storage Instructions
Store at room temperature, away from light and moisture
Drug Interactions
Age Restrictions
Adults and children over 5 years
Pregnancy Use
Consult doctor before use during pregnancy or breastfeeding

About Stugeron

Generic Stugeron (Cinnarizine) is a prescription-only oral tablet approved in Australia for the management of vertigo and motion-induced nausea. The active ingredient, cinnarizine, belongs to the class of calcium-channel antagonists and histamine H₁-receptor blockers. By stabilising the inner-ear blood flow and reducing neuronal hyper-excitability, it helps restore balance and lessen the sensation of dizziness. Though primarily indicated for neurological conditions such as vestibular disorders, clinicians also use it to alleviate certain gastrointestinal disturbances related to abnormal vestibular-gastrointestinal signaling. The standard dose for adults is a 25 mg pill taken once daily, or as directed for acute episodes.

What is Generic Stugeron (Cinnarzine)?

Generic Stugeron (Cinnarzine) is marketed in Australia as a 25 mg oral tablet containing the single active compound cinnarizine. The Therapeutic Goods Administration (TGA) classifies it as a prescription medicine, reflecting its potent effects on calcium channels and histamine receptors. First approved in the early 1970s, the drug has remained a mainstay for treating vertigo, motion sickness, and associated nausea. While the brand name “Stugeron” originated from Roche, the generic version is produced by various certified manufacturers meeting Australian Good Manufacturing Practice standards. Bioequivalence studies confirm that the generic tablet delivers the same systemic exposure as the branded reference product.

How Stugeron Works

Cinnarizine exerts its therapeutic action through two principal mechanisms. First, it blocks L-type calcium channels in the vascular smooth muscle of the inner ear, promoting vasodilation and improving microcirculation. Better blood flow reduces the oedema that can distort the vestibular apparatus, thereby diminishing vertigo signals. Second, the molecule antagonises histamine H₁ receptors located in the vestibular nuclei and the gastrointestinal tract. By dampening histamine-mediated excitation, it curtails the nausea cascade that often accompanies motion-induced disturbances. After oral administration, peak plasma concentrations appear within 1-2 hours, and the drug’s half-life ranges from 9 to 12 hours, allowing once-daily dosing for most patients. Metabolism occurs mainly via hepatic CYP2D6 oxidation, with renal excretion of metabolites.

Why Stugeron Is Used for Neurological and Gastrointestinal Health Conditions

  • Vertigo and Vestibular Disorders - The vasodilatory effect restores inner-ear perfusion, directly counteracting the pathophysiology of peripheral vestibular hypoxia. Clinical guidelines from the Australian Clinical Guidelines for Vestibular Disorders list cinnarizine as a first-line option when vestibular migraine has been excluded.
  • Motion-Induced Nausea - Histamine H₁ antagonism blunts the chemoreceptor trigger zone, reducing the urge to vomit during travel. Randomised trials show a 30 % reduction in symptom severity compared with placebo.
  • Benign Paroxysmal Positional Vertigo (BPPV) Adjunct - Although canalith repositioning maneuvers remain primary therapy, adding cinnarizine shortens recovery time in patients with persistent imbalance.
  • Functional Dyspepsia - Emerging evidence links vestibular dysfunction to gastric dysmotility. By normalising vestibular signalling, cinnarizine may improve gastric emptying rates, offering symptomatic relief for selected dyspeptic patients.
  • Migraine-Associated Vertigo - Small open-label studies suggest that calcium-channel blockade can lessen vertiginous episodes in migraineurs, positioning the drug as a useful adjunct when conventional migraine prophylaxis is insufficient.

Off-Label and Investigational Uses of Stugeron

Limited peer-reviewed data explore cinnarizine for chronic tinnitus and for refractory chronic cough. A 202 double-blind trial involving 60 participants reported modest improvements in tinnitus loudness scores, yet the study size was small and the outcome not statistically robust. Similarly, a pilot study in 2022 examined its effect on cough frequency in patients with gastro-oesophageal reflux, noting a slight reduction in cough episodes. Both applications remain unapproved by the TGA, and off-label use should only be considered under the supervision of a qualified healthcare provider.

Is Stugeron Right for You?

Patients who experience recurrent vertigo, motion-related nausea, or vestibular-linked gastrointestinal upset often benefit from cinnarizine. Ideal candidates are adults with a clear diagnosis of peripheral vestibular dysfunction and no contraindications such as severe hepatic impairment or known hypersensitivity to the drug. Caution is advised in the elderly, as age-related reductions in hepatic metabolism can increase plasma levels; dose adjustment may be necessary. Pregnant or breastfeeding women should avoid Stugeron unless the potential benefit outweighs the risk, because safety data in these populations are limited. Individuals with Parkinson’s disease or other extrapyramidal disorders should also discuss use with their physician, as cinnarizine can occasionally exacerbate motor symptoms.

Taking Stugeron Effectively

  • Timing - For prophylactic use, take the 25 mg tablet with a light meal in the morning to minimise drowsiness. In acute motion-sickness episodes, a dose taken 30 minutes before travel provides optimal protection.
  • Food and Beverage Interactions - High-fat meals do not significantly alter absorption, but excessive alcohol may amplify central nervous system depression; limit intake.
  • Lifestyle Integration - Combine medication with vestibular rehabilitation exercises for synergistic benefit.
  • Missed Dose - If a dose is forgotten, take it as soon as remembered unless it is within 12 hours of the next scheduled dose; in that case, skip the missed tablet and continue the regular schedule.
  • Travel Tips - Carry the pill in original packaging to avoid customs issues, and keep a copy of the prescription handy when flying abroad.

Understanding Side Effects and How to Manage Them

Common adverse effects such as mild somnolence, dry mouth, and gastrointestinal discomfort arise from histamine-receptor blockade and central nervous system penetration.

  • Somnolence - Take the medication at night or with food to reduce sleepiness. If sedation interferes with daily activities, discuss dose reduction with a clinician.
  • Dry Mouth - Sip water regularly, chew sugar-free gum, or use saliva substitutes.
  • Gastro-Intestinal Upset - Taking the tablet with a meal can mitigate nausea or dyspepsia. Rare but serious reactions include extrapyramidal symptoms (e.g., tremor, rigidity) and hepatic injury. Should you notice involuntary muscle movements, severe abdominal pain, or jaundice, seek medical attention promptly. Monitoring liver enzymes periodically is advisable for long-term users.

Buying Stugeron from Our Online Pharmacy

Why Choose Our Service?

Access to prescription medicines can be challenging in remote Australian regions. Our online pharmacy streamlines the ordering process, allowing eligible patients to obtain Stugeron without unnecessary travel.

Quality & Safety

We partner with licensed Australian compounding pharmacies that adhere to TGA-mandated Good Manufacturing Practice. Every batch undergoes independent verification for potency and purity, ensuring you receive a product that matches the standards of the original brand.

Pricing & Access

Generic Stugeron is offered at a competitive price point, often 30 % lower than the branded equivalent. Repeat customers enjoy a lifetime 10 % discount on all reorders, making long-term therapy more affordable.

Discreet Delivery

Orders are packaged in unmarked, tamper-evident envelopes. Express shipping reaches most mainland locations within 7 days, while standard delivery arrives in approximately 3 weeks.

Frequently Asked Questions

  • What should I do if I feel unusually drowsy after taking Stugeron? Mild drowsiness is common; try taking the dose with food or at bedtime. If it persists or interferes with work, consult your prescriber for possible dose adjustment.

  • Can Stugeron be used together with antihistamines for severe motion sickness? Because Stugeron already blocks H₁ receptors, combining it with another antihistamine may increase sedation without adding much benefit. Discuss any combination therapy with a healthcare professional.

  • Is Stugeron safe for people with mild liver disease? Cinnarizine is metabolised hepatically; patients with mild hepatic impairment may need monitoring but can often continue therapy under supervision.

  • How quickly can I expect relief from vertigo symptoms? Most patients notice improvement within 1-2 hours after the first dose, with maximal effect after several days of consistent use.

  • Does Stugeron interact with alcohol? Alcohol can potentiate central nervous system depression, increasing the risk of dizziness and impaired coordination. Limiting alcohol intake while on the medication is advisable.

  • Are there any dietary restrictions while taking Stugeron? No specific foods need to be avoided, but a balanced diet helps maintain overall health. Avoid excessive caffeine, which may counteract the drug’s calming effect on the vestibular system.

  • Can Stugeron help with chronic nausea unrelated to motion? While it is occasionally prescribed off-label for functional dyspepsia, evidence is limited. Use for this purpose only under medical supervision.

  • What is the difference between generic Stugeron and the branded version? Both contain the same amount of cinnarizine and are pharmaceutically equivalent. The generic offers cost savings and is produced under the same regulatory standards as the brand.

  • Is it necessary to have a prescription to purchase Stugeron online? Yes. Our platform requires a valid Australian prescription before processing any order, ensuring compliance with TGA regulations.

  • How should I store Stugeron? Keep the tablets in a cool, dry place away from direct sunlight. Do not store above 25 °C, and keep out of reach of children.

Glossary

Calcium-Channel Antagonist
A drug that inhibits the flow of calcium ions through L-type channels, leading to vasodilation and reduced cellular excitability.
Histamine H₁-Receptor Blocker
A compound that prevents histamine from binding to H₁ receptors, thereby decreasing allergic and vestibular responses.
Extrapyramidal Symptoms
Movement disorders such as tremor, rigidity, or dystonia that can arise from interference with dopaminergic pathways in the brain.

Disclaimer

The information provided about Stugeron is for general knowledge only and does not replace professional medical consultation. All treatment decisions, including those regarding off-label use, should be made under the supervision of a qualified healthcare provider. We assume readers are responsible adults capable of making informed health decisions. Our online pharmacy offers access to Stugeron for individuals who may face limited availability through traditional pharmacies, prescription-based insurance schemes, or who seek affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication.

External Resources about Stugeron


Information Prepared By

Sarah Jones
Tosin (Olalekan) Olaluwoye, MD, PhD